Gary Longton

9.5k total citations · 2 hit papers
87 papers, 7.1k citations indexed

About

Gary Longton is a scholar working on Oncology, Hematology and Immunology. According to data from OpenAlex, Gary Longton has authored 87 papers receiving a total of 7.1k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Oncology, 29 papers in Hematology and 14 papers in Immunology. Recurrent topics in Gary Longton's work include Hematopoietic Stem Cell Transplantation (29 papers), Global Cancer Incidence and Screening (12 papers) and AI in cancer detection (12 papers). Gary Longton is often cited by papers focused on Hematopoietic Stem Cell Transplantation (29 papers), Global Cancer Incidence and Screening (12 papers) and AI in cancer detection (12 papers). Gary Longton collaborates with scholars based in United States, South Africa and France. Gary Longton's co-authors include Margaret S. Pepe, Patricia L. Blount, Douglas S. Levine, Rainer Storb, Peter S. Rabinovitch, Claudio Anasetti, Holly Janes, Brian J. Reid, M. S. Pepe and Laura J. Prevo and has published in prestigious journals such as Proceedings of the National Academy of Sciences, JAMA and Journal of Clinical Investigation.

In The Last Decade

Gary Longton

85 papers receiving 6.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Predictors of Progression To Cancer in Barrett's Esophagus: Baseline Histology and Flow Cytometry Identify Low- and High-Risk Patient Subsets

2000 481 citations Brian J. Reid, Douglas S. Levine et al. The American Journal of Gastroenterology profile →
Diagnostic Concordance Among Pathologists Interpreting Breast Biopsy Specimens

2015 440 citations Joann G. Elmore, Gary Longton et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gary Longton United States	43	1.7k	1.6k	1.5k	1.3k	1.3k	87	7.1k
Judith Sandbank Israel	33	940 0.6×	1.5k 0.9×	1.2k 0.8×	1.0k 0.8×	782 0.6×	138	5.5k
Peter F. Thall United States	68	4.7k 2.8×	2.9k 1.7×	1.1k 0.7×	1.6k 1.2×	2.6k 2.0×	338	14.3k
James M. Crawford United States	55	1.9k 1.1×	1.7k 1.0×	2.9k 1.9×	2.0k 1.5×	1.2k 0.9×	201	10.9k
Hajime Uno United States	44	742 0.4×	2.0k 1.2×	1.0k 0.7×	424 0.3×	1.3k 1.0×	189	8.5k
M. S. Pepe United States	28	1.2k 0.7×	695 0.4×	589 0.4×	591 0.5×	806 0.6×	45	5.3k
Gary L. Rosner United States	52	1.1k 0.7×	3.0k 1.8×	517 0.3×	505 0.4×	1.5k 1.2×	207	9.1k
Stephen A. Feig United States	51	2.1k 1.3×	3.1k 1.9×	695 0.5×	637 0.5×	1.7k 1.3×	261	9.0k
Yu Shen United States	52	752 0.4×	3.1k 1.9×	2.0k 1.3×	742 0.6×	1.1k 0.9×	292	8.8k
Sin‐Ho Jung United States	47	533 0.3×	2.7k 1.6×	1.0k 0.7×	489 0.4×	1.8k 1.4×	299	8.1k
Stephen L. George United States	50	2.3k 1.3×	2.3k 1.4×	1.1k 0.7×	397 0.3×	1.5k 1.2×	172	9.2k

Countries citing papers authored by Gary Longton

Since Specialization

Citations

This map shows the geographic impact of Gary Longton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary Longton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary Longton more than expected).

Fields of papers citing papers by Gary Longton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary Longton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary Longton. The network helps show where Gary Longton may publish in the future.

Co-authorship network of co-authors of Gary Longton

This figure shows the co-authorship network connecting the top 25 collaborators of Gary Longton. A scholar is included among the top collaborators of Gary Longton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary Longton. Gary Longton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dittmar, Rachel L., Suyu Liu, Mei-Chee Tai, et al.. (2021). Plasma miRNA Biomarkers in Limited Volume Samples for Detection of Early-stage Pancreatic Cancer. Cancer Prevention Research. 14(7). 729–740. 27 indexed citations

Piepkorn, Michael W., Gary Longton, Lisa M. Reisch, et al.. (2019). Assessment of Second-Opinion Strategies for Diagnoses of Cutaneous Melanocytic Lesions. JAMA Network Open. 2(10). e1912597–e1912597. 32 indexed citations

Onega, Tracy, Raymond L. Barnhill, Michael W. Piepkorn, et al.. (2018). Accuracy of Digital Pathologic Analysis vs Traditional Microscopy in the Interpretation of Melanocytic Lesions. JAMA Dermatology. 154(10). 1159–1159. 19 indexed citations

Onega, Tracy, Donald L. Weaver, Frederick A. Spencer, et al.. (2017). The diagnostic challenge of low-grade ductal carcinoma in situ. European Journal of Cancer. 80. 39–47. 31 indexed citations

Elmore, Joann G., Anna N.A. Tosteson, Margaret S. Pepe, et al.. (2016). Evaluation of 12 strategies for obtaining second opinions to improve interpretation of breast histopathology: simulation study. BMJ. 353. i3069–i3069. 22 indexed citations

Marks, Jeffrey R., Karen S. Anderson, Paul F. Engstrom, et al.. (2014). Construction and Analysis of the NCI-EDRN Breast Cancer Reference Set for Circulating Markers of Disease. Cancer Epidemiology Biomarkers & Prevention. 24(2). 435–441. 13 indexed citations

Visintin, Irene, Ziding Feng, Gary Longton, et al.. (2008). Diagnostic Markers for Early Detection of Ovarian Cancer. Clinical Cancer Research. 14(4). 1065–1072. 307 indexed citations

Pepe, Margaret S., Ziding Feng, Gary Longton, & Joseph S. Koopmeiners. (2008). Conditional estimation of sensitivity and specificity from a phase 2 biomarker study allowing early termination for futility. Statistics in Medicine. 28(5). 762–779. 26 indexed citations

Pepe, Margaret S., Tianxi Cai, & Gary Longton. (2005). Combining Predictors for Classification Using the Area under the Receiver Operating Characteristic Curve. Biometrics. 62(1). 221–229. 194 indexed citations

10.

Stern, Jean M., Keith M. Sullivan, Susan M. Ott, et al.. (2001). Bone density loss after allogeneic hematopoietic stem cell transplantation: A prospective study. Biology of Blood and Marrow Transplantation. 7(5). 257–264. 81 indexed citations

11.

Rosenfeld, Margaret, Margaret S. Pepe, Gary Longton, et al.. (2001). Effect of choice of reference equation on analysis of pulmonary function in cystic fibrosis patients*. Pediatric Pulmonology. 31(3). 227–237. 41 indexed citations

12.

Reid, Brian J., Douglas S. Levine, Gary Longton, Patricia L. Blount, & Peter S. Rabinovitch. (2000). Predictors of Progression To Cancer in Barrett's Esophagus: Baseline Histology and Flow Cytometry Identify Low- and High-Risk Patient Subsets. The American Journal of Gastroenterology. 95(7). 1669–1676. 481 indexed citations breakdown →

13.

Etzioni, Ruth, et al.. (1999). Incorporating the Time Dimension in Receiver Operating Characteristic Curves: A Case Study of Prostate Cancer. Medical Decision Making. 19(3). 242–251. 78 indexed citations

14.

Leisenring, Wendy M., Margaret S. Pepe, & Gary Longton. (1997). A MARGINAL REGRESSION MODELLING FRAMEWORK FOR EVALUATING MEDICAL DIAGNOSTIC TESTS. Statistics in Medicine. 16(11). 1263–1281. 102 indexed citations

15.

Pepe, Margaret S., Nicole Urban, Carolyn M. Rutter, & Gary Longton. (1997). Design of a Study to Improve Accuracy in Reading Mammograms. Journal of Clinical Epidemiology. 50(12). 1327–1338. 11 indexed citations

16.

Hunt, Karen, Gary Longton, Margaret A. Williams, & Robert B. Livingston. (1996). Treatment of Malignant Mesothelioma With Methotrexate and Vinblastine, With or Without Platinum Chemotherapy. CHEST Journal. 109(5). 1239–1242. 19 indexed citations

17.

Longton, Gary, et al.. (1994). Increased risk of infection in marrow transplant patients receiving methylprednisolone for graft-versus-host disease prevention. Blood. 84(4). 1328–1332. 89 indexed citations

18.

Beatty, Patrick G., Gary Longton, E. Donnall Thomas, et al.. (1991). MARROW TRANSPLANTATION FROM HLA-MATCHED UNRELATED DONORS FOR TREATMENT OF HEMATOLOGIC MALIGNANCIES. Transplantation. 51(2). 443–447. 218 indexed citations

19.

Ladiges, Warren, et al.. (1988). SELECTIVE INHIBITION OF THE CANINE MIXED LYMPHOCYTE RESPONSE BY HLA-DR AND DP-REACTIVE MONOCLONAL ANTIBODIES. Transplantation. 45(2). 484–487. 13 indexed citations

20.

Niederwieser, Dietger, Margaret S. Pepe, Rainer Storb, Thomas P. Loughran, & Gary Longton. (1988). Improvement in rejection, engraftment rate and survival without increase in graft‐versus‐host disease by high marrow cell dose in patients transplanted for aplastic anaemia. British Journal of Haematology. 69(1). 23–28. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact